Patents by Inventor Milton J. Allison

Milton J. Allison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10653726
    Abstract: The present invention comprises methods and compositions for the reduction of oxalate in humans, animals and plants. For example, the invention provides methods and compositions for the delivery of one ore more oxalate-reducing enzymes to the intestinal tracts of persons and animals. The methods and compositions can be used in treating and preventing oxalate-related conditions.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: May 19, 2020
    Assignees: OXTHERA INTELLECTUAL PROPERTY AB, THE MILTON J. ALLISON REVOCABLE TRUST
    Inventors: Harmeet Sidhu, Milton J. Allison
  • Publication number: 20190091268
    Abstract: The present invention comprises methods and compositions for the reduction of oxalate in humans, animals and plants. For example, the invention provides methods and compositions for the delivery of one ore more oxalate-reducing enzymes to the intestinal tracts of persons and animals. The methods and compositions can be used in treating and preventing oxalate-related conditions.
    Type: Application
    Filed: September 18, 2018
    Publication date: March 28, 2019
    Applicants: OxThera Intellectual Property AB, The Milton J. Allison Revocable Trust
    Inventors: Harmeet Sidhu, Milton J. Allison
  • Patent number: 10149866
    Abstract: The present invention comprises methods and compositions for the reduction of oxalate in humans, animals and plants. For example, the invention provides methods and compositions for the delivery of one or more oxalate-reducing enzymes to the intestinal tracts of persons and animals. The methods and compositions can be used in treating and preventing oxalate-related conditions.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: December 11, 2018
    Assignees: OXTHERA INTELLECTUAL PROPERTY AB, THE MILTON J. ALLISON REVOCABLE TRUST
    Inventors: Harmeet Sidhu, Milton J. Allison
  • Publication number: 20140030324
    Abstract: The present invention comprises methods and compositions for the reduction of oxalate in humans, animals and plants. For example, the invention provides methods and compositions for the delivery of one ore more oxalate-reducing enzymes to the intestinal tracts of persons and animals. The methods and compositions can be used in treating and preventing oxalate-related conditions.
    Type: Application
    Filed: June 17, 2013
    Publication date: January 30, 2014
    Applicants: The Milton J. Allison Revocable Trust, OxThera, Inc.
    Inventors: Harmeet Sidhu, Milton J. Allison
  • Patent number: 8486389
    Abstract: The present invention comprises methods and compositions for the reduction of oxalate in humans, animals and plants. For example, the invention provides methods and compositions for the delivery of one ore more oxalate-reducing enzymes to the intestinal tracts of persons and animals. The methods and compositions can be used in treating and preventing oxalate-related conditions.
    Type: Grant
    Filed: June 15, 2004
    Date of Patent: July 16, 2013
    Assignees: Oxthera, Inc., The Milton J. Allison Revocable Trust
    Inventors: Harmeet Sidhu, Milton J. Allison
  • Publication number: 20040120941
    Abstract: This invention provides materials and procedures for the delivery of selected strains of bacteria and/or oxalate-degrading enzymes to the intestinal tracts of persons and/or domestic or zoological animals who are at increased risk for oxalate related disease because they have lost, or have inadequate concentrations of these bacteria. The administration of these bacteria and/or the relevant enzyme removes oxalate from the intestinal tract and thus reduces the amount of oxalate available for absorption and reduces the risk for oxalate related disease.
    Type: Application
    Filed: September 24, 2003
    Publication date: June 24, 2004
    Inventors: Milton J. Allison, Harmeet Sidhu
  • Patent number: 6699469
    Abstract: This invention provides materials and procedures for the delivery of selected strains of bacteria and/or oxalate-degrading enzymes to the intestinal tracts of persons and/or domestic or zoological animals who are at increased risk for oxalate related disease because they have lost, or have inadequate concentrations of these bacteria. The administration of these bacteria and/or the relevant enzyme removes oxalate from the intestinal tract and thus reduces the amount of oxalate available for absorption and reduces the risk for oxalate related disease.
    Type: Grant
    Filed: March 8, 2002
    Date of Patent: March 2, 2004
    Assignee: Ixion Biotechnology, Inc.
    Inventors: Milton J. Allison, Harmeet Sidhu
  • Publication number: 20020102238
    Abstract: This invention provides materials and procedures for the delivery of selected strains of bacteria and/or oxalate-degrading enzymes to the intestinal tracts of persons and/or domestic or zoological animals who are at increased risk for oxalate related disease because they have lost, or have inadequate concentrations of these bacteria. The administration of these bacteria and/or the relevant enzyme removes oxalate from the intestinal tract and thus reduces the amount of oxalate available for absorption and reduces the risk for oxalate related disease.
    Type: Application
    Filed: March 8, 2002
    Publication date: August 1, 2002
    Inventors: Milton J. Allison, Harmeet Sidhu
  • Patent number: 6355242
    Abstract: This invention provides materials and procedures for the delivery of selected strains of bacteria and/or oxalate-degrading enzymes to the intestinal tracts of persons and/or domestic or zoological animals who are at increased risk for oxalate related disease because they have lost, or have inadequate concentrations of these bacteria. The administration of these bacteria and/or the relevant enzyme removes oxalate from the intestinal tract and thus reduces the amount of oxalate available for absorption and reduces the risk for oxalate related disease.
    Type: Grant
    Filed: February 9, 2000
    Date of Patent: March 12, 2002
    Assignee: Ixion Biotechnology, Inc.
    Inventors: Milton J. Allison, Harmeet Sidhu
  • Patent number: 6200562
    Abstract: This invention provides materials and procedures for the delivery of selected strains of bacteria and/or oxalate-degrading enzymes to the intestinal tracts of persons who are at increased risk for oxalate related disease because they have lost, or have inadequate concentrations of these bacteria. The administration of these bacteria and/or the relevant enzyme removes oxalate from the intestinal tract and thus reduces the amount of oxalate available for absorption and reduces the risk for oxalate related disease.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: March 13, 2001
    Assignee: Ixion Biotechnology, Inc.
    Inventors: Milton J. Allison, Harmeet Sidhu